# Comparative Study of Three Different Formulations of Omega-3 (EPA+DHA)

> **NCT04159532** · PHASE4 · COMPLETED · sponsor: **SCF Pharma** · enrollment: 36 (actual)

## Conditions studied

- Healthy Adults

## Interventions

- **DIETARY_SUPPLEMENT:** MAG-EPA/MAG-DHA
- **DIETARY_SUPPLEMENT:** TG-EPA/TG-DHA
- **DIETARY_SUPPLEMENT:** EE-EPA/EE-DHA

## Key facts

- **NCT ID:** NCT04159532
- **Lead sponsor:** SCF Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-18
- **Primary completion:** 2021-02-25
- **Final completion:** 2021-02-25
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04159532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04159532, "Comparative Study of Three Different Formulations of Omega-3 (EPA+DHA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04159532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*